Dashboard
Manage Tickers

PHIOPhio Pharmaceuticals Corp.

Nasdaq phiopharma.com


$ 0.79 $ -0.07 (-8.51 %)    

Thursday, 09-May-2024 15:59:02 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.7045
$ 0.80
$ 0.00 x 0
$ 0.79 x 200
$ 0.79 - $ 0.80
$ 0.50 - $ 6.85
53,455
na
3.23M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-22-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-27-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-26-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-11-2017 03-31-2017 10-Q
30 03-30-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-13-2015 03-31-2015 10-Q
38 03-30-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

phio-pharma-q1-eps-047-up-from-315-yoy
Phio Pharma Q1 EPS $(0.47) Up From $(3.15)...
05/09/2024 22:25:38

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.47) per share. This is a 85.08 percent increase over losses of $(3.1...

phio-pharmaceuticals-q1-cash-position-65m
Phio Pharmaceuticals Q1 Cash Position $6.5M
05/09/2024 21:58:06

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 12:06:32

why-hibbett-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Hibbett Shares Are Trading Higher By 1...
04/23/2024 12:00:50

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

why-is-penny-stock-phio-pharmaceuticals-trading-higher-on-monday
Why Is Penny Stock Phio Pharmaceuticals Tr...
04/22/2024 18:29:02

Phio Pharmaceuticals unveils findings on PH-762, a promising candidate for cancer therapy. Discover its rapid cell uptake and t...

phios-intratumoral-injection-of-ph-762-significantly-inhibits-tumor-growth-in-murine-tumor-models-and-may-generate-memory-specific-t-cells-injection-in-murine-tumors-shows-the-compound-is-well-tolerated
Phio's Intratumoral Injection Of PH-762 Si...
04/22/2024 17:12:22

-Injection in murine tumors shows the compound is well tolerated-Studies support ongoing clinical trial of PH-762 as a neoadjuv...

phio-pharmaceuticals-announced-its-intasyl-platform-will-be-the-focus-of-viewpoint-a-national-program-hosted-by-dennis-quaid
Phio Pharmaceuticals Announced Its INTASYL...
04/03/2024 11:34:18

phio-pharma-q4-eps-017-may-not-be-comparable-to-130-estimate-cash-balance-of-85m
Phio Pharma Q4 EPS $(0.17) May Not Be Comp...
04/02/2024 11:58:13

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 21:33:35

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

phio-pharmaceuticals-presenting-data-showing-intasyl-may-result-in-more-effective-cell-therapy-for-hematological-malignancies
Phio Pharmaceuticals Presenting Data Showi...
03/21/2024 11:38:08

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencin...

phio-pharmaceuticals-announces-addition-of-clinical-trial-sites-at-banner-md-anderson-cancer-center
Phio Pharmaceuticals Announces Addition of...
03/13/2024 18:01:41

https://www.sec.gov/Archives/edgar/data/1105806/000093583624000282/evok13g.htm

phio-pharmaceuticals-announces-patent-granted-by-uspto-strengthening-the-companys-intellectual-property-position-in-treating-aging-skin-and-skin-disorders
Phio Pharmaceuticals Announces Patent Gran...
03/06/2024 15:31:44

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencin...

hc-wainwright--co-maintains-buy-on-phio-pharma-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Phio ...
02/06/2024 11:42:27

HC Wainwright & Co. analyst Vernon Bernardino maintains Phio Pharma (NASDAQ:PHIO) with a Buy and lowers the price target...

phio-pharmaceuticals-to-present-preclinical-data-for-intasyl-at-10th-immunotherapy-of-cancer-conference
Phio Pharmaceuticals To Present Preclinica...
01/31/2024 13:40:29

--New preclinical data to be presented at Immunotherapy Conference in Germany

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
01/31/2024 13:05:57

why-nxu-shares-are-trading-higher-by-around-42-here-are-20-stocks-moving-premarket
Why Nxu Shares Are Trading Higher By Aroun...
12/14/2023 13:27:24

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining inv...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
12/08/2023 21:30:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION